Antacids are the most used for treating dyspepsia discomfort, sour stomach, acid indigestion, and stomach upset. As they start to work in seconds, they're used to relieve the symptoms in the fastest way. Antacids are available in convenient chewable tablets or as a liquid and are available without any prescription. Also, the antacids are low-prices making antacids a popular product.

Antacids start weakening the acids in the stomach immediately after entering the body. If the acid is weaker there lesser chances of heartburn. Antacids are made up of various ingredients like calcium carbonate, aluminum hydroxide, magnesium hydroxide, and sodium bicarbonate.

Some antacids also consist of simethicone which helps in getting your body to get rid of gas. There are two types of drugs which help in the weakening of the acid in the stomach: histamine antagonists and proton pump inhibitors. Antacids examples mainly include Aluminum hydroxide gel, Calcium carbonate, Magnesium hydroxide, Gaviscon, Gelusil, Maalox, Mylanta, Rolaids, Pepto-Bismol. There are also some side effects of antacids like diarrhea, changes in the color of bowel movements, constipation, and stomach cramps.

Market scope and structure analysis:

COVID-19 scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Owing to such factors, COVID 19 is expected to have a significant impact on the antacids market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

High frequency of acidity due to change in lifestyle which involves deskbound jobs, poor quality of sleep, irregular dietary habits, which results in an increase in acidity level of the stomach and it leads to gastroesophageal reflux disease, growing geriatric population are suffering from Gastroesophageal Reflux Disease (GERD), and side effects of drugs like non-steroidal, anti-inflammatory drugs are the major factors affecting the growth of antacids market positively.

The rising rate of senior citizens is increasing significantly and the geriatric population is dealing with acid reflux. In the elderly population, the acidic issues are recurrent and infrequent, patients like this often suffer from several symptomatic disorders, like erosive esophagitis, Barrett esophagus, and esophageal cancer, where a combination of therapies are used for the treatment and the use of antacids significantly rises in cases like this.

There is also an evident growth in e-commerce and is likely to increase the demand for antacids through online retailing channels in the past few years. Consequently, the rising popularity of e-commerce and rush in the number of online medicine providers is expected to impact the overall growth of the market positively.

On the other hand, manufacturers are striving to reposition their brand identity, antacids in melt-in-mouth micro-granules and gummies are increasing and gaining high demand.

Side effects of antacids are the major restraint for the antacids market. These sides effects mainly include antacids include dose-dependent rebound hyperacidity and milk-alkali syndrome. Antacids that contain aluminum hydroxide cause side effects like constipation, osteomalacia, aluminum-intoxication, and hypophosphatemia. Additionally, when antacids are consumed with other acidic drugs it leads to the absorption of both the drugs resulting in reduced efficiency of both the drugs.

New product launches to flourish the market:

On November 2nd, 2019, the U.S.FDA to lessen the risk of carcinogen NDMA and recalled antacid ranitidine.

Surge in usage in hospital applications:

Hospital pharmacies, retail pharmacies, and online pharmacies are the major end-users of the antacid market. Amongst these, the antacid availability is shifting from hospital pharmacies to others. The unmatched growth of e-commerce websites and applications coupled with the convenience of home delivery of therapeutics is turning online pharmacies as a standard distribution channel for antacids.

Key segments covered:

Key benefits of the report:

• This study presents the analytical depiction of the global Antacids industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Antacids market share.
• The current market is quantitatively analyzed from 2020 to 2027 to highlight the global Antacids market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed global Antacids market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Antacids Market research report:

• What are the leading market players active in the Antacids market?
• What the current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What are the projections for the future that would help in taking further strategic steps?

 Key Market Segments

 
Key Market Players

• GlaxoSmithKline plc
• Pfizer Inc
• Bayer AG
• Dr. Reddy's Laboratories Ltd
• AstraZeneca PLC
• Boehringer Ingelheim GmbH
• Sun Pharmaceuticals Industries Ltd
• Takeda Pharmaceutical Company Limited
• Abbott Laboratories
• WellSpring Ph